Impedimed (IPD)

Shares / Stock Code


Stock Exchange / Sharemarket


ImpediMed (IPD) is an Australian-based medical device company that develops medical devices to enable early detection and monitoring of secondary lymphoedema in cancer survivors before the onset of symptoms detectable using the most commonly used clinical technique. It was listed on ASX on 24 October, 2007.

The Company operates in two segments: Medical, which is a supplier of non-invasive medical devices to two under-served markets, such as the assessment of individuals at risk of secondary lymphoedema and the monitoring of body composition and hydration, and Test & Measurement, which is a supplier of power precision testing and measuring equipment.

Impedimed (IPD) Products and Services

  • The development and sale internationally of medical devices for diagnosing and monitoring human disorders and diseases

Impedimed (IPD) Locations and Subsidiaries

ImpediMed Head Office
Unit 1, 50 Parker Court,
Phone: (07) 3860 3700
Fax: (07) 3260 1225

Impedimed (IPD) Share Price

Submitted by ASX Listed Company on 22 April, 2010 - 23:40